Special Issue Title:

COVID‐19 Pandemic Impact on Gynaecological Cancers

Deadline for manuscript submissions: 31 May 2022

Print Special Issue Flyer (1)

Special Issue Editor

  • Guest Editor

    Giuseppe Carlo Iorio, MDE-MailWebsite

    Department of Oncology, Radiation Oncology, University of Turin, Turin, Italy

    Interests: radiation oncology; radiobiology; pelvic malignancies; prostate cancer; HNC; GI cancer; breast cancer; lymphomas

Special Issue Information

Dear Colleagues,

Coronavirus Disease 2019 (COVID-19) at the end of May 2021 has surpassed 167,000,000 cases and 3,400,000 deaths worldwide due to a severe acute respiratory syndrome (SARS-CoV-2), leading to heavy stress for the healthcare system.

Cancer patients are more susceptible to develop an infection than people without cancer because of their immunosuppression caused by the disease and treatments (surgery, radiotherapy, and chemotherapy). Indeed, chemo- and radiotherapy-related hematologic toxicity, particularly leukopenia and lymphopenia, play a pivotal role in this immunosuppressed state. Therefore, these patients are at higher risk of infection with COVID-19 and a much higher risk of developing more severe forms. Nonetheless, lymphopenia has also proved to affect the oncological prognosis of cancer patients, and thus its importance has been remarked during the present Pandemic. Given this epidemiological context, guidelines for patients with Gynaecological Cancers requiring multidisciplinary management during the COVID-19 Pandemic have represented a crucial step in limiting their infection while maintaining their chances for a cure. 

Therefore, in the present Special Issue, we aim to present evidence on the management of Gynaecological malignancies (and Breast Cancer) during the COVID-19 Pandemic and on the critical role of treatment-tailoring to avoid hematologic toxicity given its implications during and beyond the Pandemic.

Dr. Giuseppe Carlo Iorio

Guest Editor


Gynaecological Cancers;COVID-19 Pandemic;Ovarian Cancer;Endometrial Cancer;Cervical Cancer;Breast Cancer;Radiotherapy;Chemotherapy;Surgery;Toxicity

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access journal published by MRE Press. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Published Papers (1 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time